Modified recombinant factor viii and von willebrand factor...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/37 (2006.01) A61K 47/48 (2006.01) C07K 14/755 (2006.01)

Patent

CA 2704234

The present invention provides novel methods of increasing the survival of a coagulation protein by inhibiting the interaction with a clearance receptor. The invention also provides methods of preparing compositions that inhibit coagulation protein clearance receptors. Conjugated coagulation proteins, including compositions and formulations thereof, are also provided by the present invention.

L'invention concerne de nouveaux procédés permettant d'augmenter la survie d'une protéine de coagulation en inhibant l'interaction avec un récepteur de clairance. L'invention concerne également des procédés de préparation de compositions qui inhibent les récepteurs de clairance des protéines de coagulation. L'invention concerne également des protéines de coagulation conjuguées, ainsi que des compositions et des formulations les contenant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Modified recombinant factor viii and von willebrand factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified recombinant factor viii and von willebrand factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified recombinant factor viii and von willebrand factor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1486443

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.